American Society of Hematology: CAR-T Safe and Effective on an Outpatient Basis in Community Hospitals
October 01, 2024
October 01, 2024
WASHINGTON, Oct. 1 (TNSres) -- The American Society of Hematology issued the following news release:
* * *
Study of liso-cel in patients with relapsed or refractory large B-cell lymphoma points to the benefits of bringing advanced therapies closer to patients, minimizing hospitalizations
* * *
In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, pa . . .
* * *
Study of liso-cel in patients with relapsed or refractory large B-cell lymphoma points to the benefits of bringing advanced therapies closer to patients, minimizing hospitalizations
* * *
In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, pa . . .